SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000950133-04-003865
Filing Date
2004-10-21
Accepted
2004-10-21 14:55:22
Documents
1
Group Members
BIOTECH TARGET N.V.

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 w67797sc13gza.htm SC 13G/A 47502
  Complete submission text file 0000950133-04-003865.txt   49471
Mailing Address VODERGASSE 3 SWITZERLAND SCHAFFHAUSEN V8 CH-8300
Business Address VODERGASSE 3 SWITZERLAND SCHAFFHAUSEN V8 CH-8300 411724 59 59
BB BIOTECH AG (Filed by) CIK: 0000924223 (see all company filings)

State of Incorp.: V8 | Fiscal Year End: 1231
SIC: 0000

Mailing Address
Business Address 8995 WESTSIDE PARKWAY ALPHARETTA GA 30004 6783362500
ATHEROGENICS INC (Subject) CIK: 0001107601 (see all company filings)

IRS No.: 582108232 | State of Incorp.: GA | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-60563 | Film No.: 041089511
SIC: 2834 Pharmaceutical Preparations